These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 31430456)

  • 1. Pinolenic acid ameliorates oleic acid-induced lipogenesis and oxidative stress via AMPK/SIRT1 signaling pathway in HepG2 cells.
    Zhang J; Zhang SD; Wang P; Guo N; Wang W; Yao LP; Yang Q; Efferth T; Jiao J; Fu YJ
    Eur J Pharmacol; 2019 Oct; 861():172618. PubMed ID: 31430456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin Modulates lipid Metabolism in HepG2 Cells Cultured in High Concentrations of Oleic Acid: AMPK Pathway Activation may Play an Important Role.
    Mi Y; Tan D; He Y; Zhou X; Zhou Q; Ji S
    Cell Biochem Biophys; 2018 Dec; 76(4):463-470. PubMed ID: 30324559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes.
    Kang OH; Kim SB; Mun SH; Seo YS; Hwang HC; Lee YM; Lee HS; Kang DG; Kwon DY
    Int J Mol Med; 2015 Mar; 35(3):803-9. PubMed ID: 25605057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hovenia Dulcis Extract Reduces Lipid Accumulation in Oleic Acid-Induced Steatosis of Hep G2 Cells via Activation of AMPK and PPARα/CPT-1 Pathway and in Acute Hyperlipidemia Mouse Model.
    Kim B; Woo MJ; Park CS; Lee SH; Kim JS; Kim B; An S; Kim SH
    Phytother Res; 2017 Jan; 31(1):132-139. PubMed ID: 27762456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavonones from
    Guo WW; Wang X; Chen XQ; Ba YY; Zhang N; Xu RR; Zhao WW; Wu X
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30154382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berbamine induced AMPK activation regulates mTOR/SREBP-1c axis and Nrf2/ARE pathway to allay lipid accumulation and oxidative stress in steatotic HepG2 cells.
    Sharma A; Anand SK; Singh N; Dwivedi UN; Kakkar P
    Eur J Pharmacol; 2020 Sep; 882():173244. PubMed ID: 32526241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells.
    Yin J; Luo Y; Deng H; Qin S; Tang W; Zeng L; Zhou B
    J Ethnopharmacol; 2014 May; 154(1):229-39. PubMed ID: 24735863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydrocurcumin ameliorates the lipid accumulation, oxidative stress and insulin resistance in oleic acid-induced L02 and HepG2 cells.
    Yu Q; Liu Y; Wu Y; Chen Y
    Biomed Pharmacother; 2018 Jul; 103():1327-1336. PubMed ID: 29864915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis.
    Patel TP; Rawal K; Soni S; Gupta S
    Biomed Pharmacother; 2016 Oct; 83():785-791. PubMed ID: 27490779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of daphnetin on lipid metabolism, insulin resistance and oxidative stress in OA‑treated HepG2 cells.
    Liu Y; Liao L; Chen Y; Han F
    Mol Med Rep; 2019 Jun; 19(6):4673-4684. PubMed ID: 30957185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydromyricetin ameliorates oleic acid-induced lipid accumulation in L02 and HepG2 cells by inhibiting lipogenesis and oxidative stress.
    Xie C; Chen Z; Zhang C; Xu X; Jin J; Zhan W; Han T; Wang J
    Life Sci; 2016 Jul; 157():131-139. PubMed ID: 27265384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptotanshinone from the
    Nagappan A; Kim JH; Jung DY; Jung MH
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition of oleic acid induced hepatic lipogenesis and the promotion of lipolysis by caffeic acid via up-regulation of AMP-activated kinase.
    Liao CC; Ou TT; Huang HP; Wang CJ
    J Sci Food Agric; 2014 Apr; 94(6):1154-62. PubMed ID: 24027117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gentiopicroside Ameliorates Oxidative Stress and Lipid Accumulation through Nuclear Factor Erythroid 2-Related Factor 2 Activation.
    Jin M; Feng H; Wang Y; Yan S; Shen B; Li Z; Qin H; Wang Q; Li J; Liu G
    Oxid Med Cell Longev; 2020; 2020():2940746. PubMed ID: 32655764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin decreases oleic acid-induced lipid accumulation via AMPK phosphorylation in hepatocarcinoma cells.
    Kang OH; Kim SB; Seo YS; Joung DK; Mun SH; Choi JG; Lee YM; Kang DG; Lee HS; Kwon DY
    Eur Rev Med Pharmacol Sci; 2013 Oct; 17(19):2578-86. PubMed ID: 24142602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Caffeoyl, 4-dihydrocaffeoylquinic acid from Salicornia herbacea attenuates high glucose-induced hepatic lipogenesis in human HepG2 cells through activation of the liver kinase B1 and silent information regulator T1/AMPK-dependent pathway.
    Pil Hwang Y; Gyun Kim H; Choi JH; Truong Do M; Tran TP; Chun HK; Chung YC; Jeong TC; Jeong HG
    Mol Nutr Food Res; 2013 Mar; 57(3):471-82. PubMed ID: 23349077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.
    Luo L; Fang K; Dan X; Gu M
    Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
    Long JK; Dai W; Zheng YW; Zhao SP
    Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.